Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Selecting a total market ETF for a Roth IRA involves evaluating expense ratios and tracking performance. This guide outlines practical criteria.
28,330 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Turn midweek into a strategic advantage. This guide shares 10 Wednesday reads tailored for investors, with clear take...
A big order from China could reshape Boeing's outlook and affect your investments. This guide breaks down the implica...
A wide-reaching benefits-fraud crackdown in Massachusetts resulted in 15 charges for schemes totaling more than $1.4 ...
Big events bring big costs beyond ticketing and catering. Explore what a six-figure NYC permit can teach about budget...
Start your week with smart, practical investing ideas. This 10-item Monday Reads digest breaks down market trends, po...
At a key investor conference, Micron revealed strategic moves and market signals that could alter its trajectory. Her...
Refinances powered a broad uplift in home borrowing, with mortgage applications jump 11% in the latest MBA weekly sur...
A Magnite insider disclosed a sizable open-market sale, sparking questions for investors. This guide breaks down what...
XRP has fallen from recent highs, but a rebound back above $2 is on the table if key catalysts align. This guide brea...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Visa and Mastercard lead the global payments world, forming a true duopoly. This article breaks down which stock off...